These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 17257131

  • 1. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
    Nowicki M, Ostalska-Nowicka D, Kaczmarek M, Miskowiak B, Witt M.
    Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131
    [Abstract] [Full Text] [Related]

  • 2. [Wilms tumor as a novel model of angiogenesis in childood nephropathies].
    Nowicki M, Ostalska-Nowicka D, Zachwieja J, Lewandowska L, Kaczmarek-Kanold M, Miśkowiak B.
    Przegl Lek; 2006 Feb; 63 Suppl 3():87-9. PubMed ID: 16898498
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N, Yano H, Komai K, Nishida T, Kamura T, Kojiro M.
    Cancer; 2004 Sep 15; 101(6):1364-74. PubMed ID: 15368324
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour.
    Ozluk Y, Kilicaslan I, Gulluoglu MG, Ayan I, Uysal V.
    Pathology; 2006 Oct 15; 38(5):408-14. PubMed ID: 17008278
    [Abstract] [Full Text] [Related]

  • 5. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG, Gu WZ, Zhou YB, Tang HF, Li MJ, Ma WX.
    Eur J Clin Invest; 2008 Dec 15; 38(12):931-8. PubMed ID: 19021718
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
    Eur J Surg Oncol; 2007 Apr 15; 33(3):294-300. PubMed ID: 17129704
    [Abstract] [Full Text] [Related]

  • 8. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S, Bergelin N, Löf C, Vainio M, Andersson S, Törnquist K.
    Endocr Relat Cancer; 2008 Jun 15; 15(2):521-34. PubMed ID: 18509004
    [Abstract] [Full Text] [Related]

  • 9. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.
    Clin Cancer Res; 2000 Nov 15; 6(11):4265-71. PubMed ID: 11106242
    [Abstract] [Full Text] [Related]

  • 10. Expression and localization of HGF and met in Wilms' tumours.
    Alami J, Williams BR, Yeger H.
    J Pathol; 2002 Jan 15; 196(1):76-84. PubMed ID: 11748645
    [Abstract] [Full Text] [Related]

  • 11. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
    Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Van den Heuvel MM, Noordzij MA, Nijman RJ, Soliman EH, van Steenbrugge GJ.
    Br J Cancer; 2001 Nov 16; 85(10):1557-63. PubMed ID: 11720445
    [Abstract] [Full Text] [Related]

  • 12. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S, Bezdekova M, Brychta T, Tichy M.
    Neoplasma; 2008 Nov 16; 55(4):273-9. PubMed ID: 18505336
    [Abstract] [Full Text] [Related]

  • 13. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.
    Onofri C, Losa M, Uhl E, Stalla GK, Renner U.
    Exp Clin Endocrinol Diabetes; 2008 Mar 15; 116(3):152-7. PubMed ID: 18205092
    [Abstract] [Full Text] [Related]

  • 15. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
    Yang J, Wu HF, Qian LX, Zhang W, Hua LX, Yu ML, Wang Z, Xu ZQ, Sui YG, Wang XR.
    Asian J Androl; 2006 Mar 15; 8(2):169-75. PubMed ID: 16491267
    [Abstract] [Full Text] [Related]

  • 16. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA, Van Steenbrugge GJ, Van Der Kwast TH, Sudaryo MK, Noordzij MA, Nijman RJ.
    J Urol; 2002 Aug 15; 168(2):681-6. PubMed ID: 12131349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
    Niu ZB, Wang CL, Hou Y, Yang Y, Gao H.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct 15; 9(5):461-4. PubMed ID: 17937859
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov 15; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.